4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-19-006857
President & CEO acquired 5,729 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
USMAN NASSIM · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-01-31 | Exercise or conversion : show line 1 in the form | +5,729 | $4.63 | $26,525 | 11,041 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-01-31 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −5,729 | $4.63 | 2027-07-11 | 5,729 | 269,271 | D |
Loading xslF345X03/doc4.xml…